Wendy Mcdermott

Human Resources Officer at LEXICON PHARMACEUTICALS, INC.

Net worth: 625 376 $ as of 31/08/2026

Health Technology

Commercial Services

Consumer Services

Profile

Ms. Wendy E.
Mcdermott is a Senior Vice President-Human Resources at Lexicon Pharmaceuticals, Inc. Ms. Mcdermott was previously employed as a Chief People Officer by Rafael Pharmaceuticals, Inc. and a Vice President-Human Resources by Sanofi Corp.
She received her undergraduate degree from State University of New York College at Plattsburgh.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LEXICON PHARMACEUTICALS, INC. 0.06%	06/03/2026	277,945 ( 0.06% )	625 376 $	31/08/2026

Wendy Mcdermott active positions

Companies	Position	Start
LEXICON PHARMACEUTICALS, INC.	Human Resources Officer	01/01/2022

All active positions of Wendy Mcdermott

Former positions of Wendy Mcdermott

Companies	Position	End
Cornerstone Pharmaceuticals, Inc. Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology	Human Resources Officer	01/01/2022
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Human Resources Officer	01/01/2019

See the detail of Wendy Mcdermott's experience

Training of Wendy Mcdermott

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wendy Mcdermott's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Cornerstone Pharmaceuticals, Inc. Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology	Commercial Services
State University of New York College at Plattsburgh State University of New York College at Plattsburgh Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Health Technology